Table 5.

Age group specific prevalence rates

	Mahdi-Rogers and Hughes [9], 2014		Rajabally et al.[18], 2009 EFNS/PNS 2006 criteria [49]		Rajabally et al.[18], 2009 AAN criteria [6]		Iijima et al.[34], 2008		Chiò et al. [11], 2007		McLeod et al. [13], 1999
Juvenile prevalence	0–9 years	0.00	0–19 years	1.26 (0.26–3.69)	0–19 years	0.42 (0.01–2.34)	0–15 years	0.23	0–19 years	0.57 (0.22–1.24)	0–9 years	0.23
per 100, 000 population	10–19 years	0.46									10–19 years	0.48
(95% CI)*
Adult prevalence per	20–29 years	0.21	20–59 years	2.51 (1.34–4.30)	20–59 years	1.16 (0.43–2.52)	15 + years	1.83	20–39 years	0.43 (0.16–0.94)	20–29 years	0.57
100, 000 population	30–39 years	0.51	60+ years	14.37 (9.69–20.51)	60+ years	5.74 (2.97–10.04)	15–55 years	1.50	40–59 years	2.99 (2.19–3.98)	30–39 years	1.27
(95% CI)*	40–49 years	3.01					55+ years	2.31	60–79 years	9.45 (7.88–11.25)	40–49 years	2.45
	50–59 years	2.61							80 ≥ years	8.78 (5.68–13.00)	50–59 years	1.81
	60–69 years	8.90									60–69 years	6.10
	70–79 years	11.60									70–79 years	6.69
	80–89 years	8.85									80–89 years	2.74
	≥90 years	0.00									≥90 years	–

^*Crude rate, if not specified otherwise.